172@29@17@249!~!172@29@0@53!~!|news|india|coronavirus-pandemic-india-becomes-3rd-country-to-register-25-lakh-cases-5706591.html!~!news|moneycontrol|com!~!|controller|infinite_scroll_article.php!~!is_mobile=false
Moneycontrol
Subscribe to PRO at just Rs.33 per month. Use code SUPERPRO
you are here: HomeNewsIndia
Last Updated : Aug 15, 2020 10:58 AM IST | Source: Moneycontrol.com

Coronavirus pandemic | India becomes 3rd country to register 25 lakh cases

India has been reporting over 60,000 cases daily since August 7, barring August 11 when the country registered 53,601 new instances of the infection.

India's COVID-19 tally on August 15 went past the 25 lakh just two days after it had reached the 24-lakh mark, with a spike of 65,002 new coronavirus cases. Eighteen lakh people have so far recuperated from the disease pushing the recovery rate to 71.61 percent, Union health ministry data showed.

India has been reporting over 60,000 cases daily since August 7, barring August 11 when the country registered 53,601 new instances of the infection.

The COVID-19 caseload stood at 25,26,192, while the death-toll climbed to 49,036 with 996 people succumbing to the disease in 24 hours, the data updated on Saturday 8 am showed.

Close

Coronavirus India News LIVE Updates

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Case fatality rate has declined to 1.94 percent.

There are 6,68,220,active cases of coronavirus infection in the country which is 26.45 percent of the total caseload, while the number of recoveries has risen to 18,08,936.

India's COVID-19 tally had crossed the 20-lakh mark on August 7.

According to the Indian Council of Medical Research (ICMR), in total 2,85,63,095 samples have been tested up to August 14 of which 8,68,679 were examined on Friday, the highest in a day so far.

Follow our full coverage of the coronavirus pandemic here.

(With PTI inputs)
First Published on Aug 15, 2020 10:40 am
Sections